Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical Practice
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
2008 • 805 citations
Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling
2007 • 567 citations
The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies
2008 • 376 citations
Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations
2008 • 219 citations
Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned
2008 • 157 citations
Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans
2008 • 122 citations
Integration and Use of Biomarkers in Drug Development, Regulation and Clinical Practice: a US Regulatory Perspective
2008 • 113 citations
BiDil for Heart Failure in Black Patients: The U.S. Food and Drug Administration Perspective
2007 • 99 citations
The Critical Path of Warfarin Dosing: Finding an Optimal Dosing Strategy Using Pharmacogenetics
2008 • 75 citations
Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan
2008 • 71 citations
Individual Genomes Instead of Race for Personalized Medicine
2008 • 71 citations
Genetic Variation in Drug Transporters in Ethnic Populations
2008 • 56 citations
Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis
2008 • 39 citations
Characteriation of Clinical Data Packages Using Foreign Data in New Drug Applications in Japan
2007 • 7 citations